Clinical trial
Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer…
NCT00485953 · Susan L. Greenspan, Other · Completed
Key facts
| NCT number | NCT00485953 |
|---|---|
| Title | Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy |
| Official title | The Effect of Bisphosphonate on Bone Mass and Bone Turnover in Elderly, Postmenopausal Women With Breast Cancer Following Initiation of Aromatase Inhibitor Therapy |
| Acronym | REBBeCA II |
| Lead sponsor | Susan L. Greenspan, Other |
| Collaborators | University of Pittsburgh |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bone Loss, Osteoporosis, Breast Cancer |
| Intervention type | Drug |
| Interventions | risedronate |
| Enrollment | 109 |
| Start date | Sep 1, 2007 |
| Primary completion | Mar 1, 2013 |
| Completion | Mar 1, 2013 |
| First posted | Jun 13, 2007 |
| Last update posted | Oct 13, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: